ARTICLE | Finance
E-scape's expansion
What neurology play E-Scape plans to do with its $63M series A round
July 15, 2017 2:33 AM UTC
The opportunity to take up a second asset that will expand E-Scape Bio Inc.'s pipeline and diversify its clinical risk led the company to bring two new investors on board and extend its series A round, increasing the target to $63 million.
Apart from a June SEC filing related to the extension, the company had been keeping itself under wraps. It formally announced the extension and new investors July 12...
BCIQ Company Profiles
BCIQ Target Profiles